1. Karch, Celeste M, Goate, Alison M. 2014. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. In Biological psychiatry, 77, 43-51. doi:10.1016/j.biopsych.2014.05.006. https://pubmed.ncbi.nlm.nih.gov/24951455/
2. Schwartzentruber, Jeremy, Cooper, Sarah, Liu, Jimmy Z, Beltrao, Pedro, Bassett, Andrew. 2021. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes. In Nature genetics, 53, 392-402. doi:10.1038/s41588-020-00776-w. https://pubmed.ncbi.nlm.nih.gov/33589840/
3. Deneka, Alexander, Korobeynikov, Vladislav, Golemis, Erica A. 2015. Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members. In Gene, 570, 25-35. doi:10.1016/j.gene.2015.06.062. https://pubmed.ncbi.nlm.nih.gov/26119091/
4. Li, Ailin, Zhang, Weiwei, Xia, Huifang, Qiu, Xueshan, Wang, Enhua. 2016. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 15157-15164. doi:. https://pubmed.ncbi.nlm.nih.gov/27677288/
5. Lu, Cong, Hu, Dong, Zheng, Jin'e, Huang, Shiang, Yao, Junxia. 2022. A Six-Gene Risk Model Based on the Immune Score Reveals Prognosis in Intermediate-Risk Acute Myeloid Leukemia. In BioMed research international, 2022, 4010786. doi:10.1155/2022/4010786. https://pubmed.ncbi.nlm.nih.gov/35528167/